Computer programs relating to assays for the diagnosis of diseases, computer programs relating to chemical markers for disease state, computer programs relating to performing diagnostics for diseases, computer programs relating to determining targets for drugs, computer programs relating to determining protein and peptide sequences, scientific instruments for developing assays for the diagnosis of diseases, scientific instruments for developing chemical markers of diseases states, scientific instruments for performing diagnostics for diseases, scientific instruments for determining targets for drugs, and scientific instruments of determining protein and peptide sequences.

Developing assays for the diagnosis of diseases; developing chemical markers for disease states; performing diagnostics for diseases; determining targets for drugs; determining protein and peptide sequences; developing methodologies relating to the foregoing, and the operation of a business dealing in scientific instrumentation for performing the foregoing services.

Drug discovery services; pharmaceutical research services; pre-clinical screening, and clinical research and evaluation services; proteomics and pharmacology research services; development of human disease models for use in evaluation of drugs and discovery of new drugs; drug discovery, drug screening, pre-clinical, and pharmaceutical programs; compilation of databases for use in pharmaceutical research; compilation of databases for use in research into protein functions; design of computer models for use in pre-clinical, clinical and pharmaceutical research; consultancy, information and advisory services for all the aforesaid services.

Discovery and development of medicines and diagnostics and integrated biophysical services including three-dimensional structure determination, functional determination and biophysical/biochemical determination and biophysical and chemical computational analysis.

Systems and computer programs for assays in the diagnosis of diseases; systems and computer programs for chemical markers for disease states; systems and computer programs for performing diagnostics for diseases; systems and computer programs for determining targets for drugs; systems and computer programs for determining protein and peptide sequences; and scientific instruments, namely, mass spectrometers, automated sample preparers for mass spectrometers, and parts and accessories for the foregoing, all for developing assays for the diagnosis of diseases, developing chemical markers for disease states, performing diagnostics for diseases, determining targets for drugs, and determining protein and peptide sequences.

Diagnosing diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, and testing candidate drug compounds for activity; scientific research for others in the fields of the diagnosis of diseases, developing chemical markers for disease states, determining targets for drugs, determining protein and peptide sequences, identifying and/or determining protein-protein, protein-ligand, protein-nucleic acid, protein-small molecule or drug interactions, testing candidate drug compounds for activity, and developing methodologies relating to the foregoing.

Computer programs relating to assays for the diagnosis of diseases, namely computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely computer programs for accepting analysis results and for determining therefrom which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences, namely mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and micro-fluidic sample processing apparatus.

Developing assays for the diagnosis of diseases; developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases, namely analyzing and reporting on patient specimens; determining biological targets for drugs, namely determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences, for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely developing bioanalytical methods to increase the throughput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services, and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; and the operation of a business which provides to users scientific instrumentation such as mass spectrometers, electrophoresis analyzers, separation apparatus such as liquid chromatographs and capillary electrophoresis apparatus, optical detection systems such as ultraviolet, fluorescence and chemiluminescence detectors, microfluidic apparatus, and sample preparation apparatus.

Diagnostic kits consisting primarily of protein capture agents and antibodies, buffers, and reagents for use in disease testing, health monitoring and more generally, predictive, preventive, personalized and participatory medicine.

Biochemicals, namely, biochemical markers; biochemicals, namely, proteins produced by human genes.

Research, development, consultation, and laboratory services pertaining to biotechnologies and gene therapy.

Computer programs relating to assays for the diagnosis of diseases, namely, computer programs which utilize data from a patient specimen assay and compare it to values which are considered to be normal, and computer programs for automatically performing all or a portion of the disease diagnostic process; computer programs relating to chemical markers for disease states, namely, computer programs for monitoring several disease states using two or more chemical markers in each assay and for comparing the concentration of each marker with a database; computer programs for performing diagnostics for diseases by analyzing the results of an assay and providing an indication of possible disease states; computer programs relating to determining targets for drugs, namely, computer programs for inspecting and analyzing databases of biological processes and predicting potential drug targets; computer programs relating to determining protein and peptide sequences, namely, computer programs for accepting analysis results and for determining there from which biological substances are present and the structure of such biological substances; scientific instruments for developing assays for the diagnosis of diseases, and for developing chemical markers for disease states, and for performing diagnostics for diseases, and for determining targets for drugs, and for determining protein and peptide sequences, namely, mass spectrometers, sample separation apparatus, sample enrichment apparatus, sample preparation apparatus, optical detectors, and microfluidic sample processing apparatus.

Developing assays for the diagnosis of diseases, developing chemical markers which indicate the presence of disease states; performing diagnostics for diseases, namely, analyzing and reporting on patient specimens; determining biological targets for drugs, namely, determining biological processes which are susceptible to being affected by drugs, in order that the drugs may alleviate disease states and conditions in humans and animals; determining protein and peptide sequences, for the purposes of identifying protein or peptide drug targets, and for developing sequencing databases; developing methodologies relating to the foregoing services, namely, developing bioanalytical methods to increase the throughput of the identification and characterization of biological substances such as proteins used as biomarkers for a diagnosis or as drug targets, and developing biochemistry processes and instrumentation for said foregoing services, and developing simplified methods of performing said foregoing services, and developing methods to reduce the sample sizes needed, and to increase the reliability of assays; and the operation of a business which provides to users scientific instrumentation such as mass spectrometers, electrophoresis analyzers, separation apparatus such as liquid chromatographs and capillary electrophoresis apparatus, optical detection systems such as ultraviolet, fluorescence and chemiluminescence detectors, microfluidic apparatus, and sample preparation apparatus.